How AstraZeneca’s $400bn deal unravelled

FT · August 12, 2026

Generating summary...

Enjoying OptionsWhisper?

Built by a solo developer. Free and curated for you.

Rate on the App Store Upgrade to Pro

Original at FT → Search for more →

More from the feed

BLOOMBERG Presight CEO: AI Productivity Needed Despite Conflict just now

BLOOMBERG ABN Amro Profit Beats, Boosts Outlook for Key Revenue Source just now

BLOOMBERG Godrej Consumer Shares Plunge After CEO’s Sudden Resignation 1h ago

BLOOMBERG StanChart COO Sees AI Boosting Productivity 1h ago

BLOOMBERG AGL Jumps Most in Six Months on Strong Battery Performance 1h ago

OptionsWhisperThe market, whispered.›